AKTX
Akari Therapeutics Plc
Going-concern doubt
— flagged May 19, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company’s ability to continue as a going concern for at least a one-year period following the issuance of these condensed consolidated financial statements.”View the 10-Q filed May 19, 2026
Company with tickers: AKTX
CIK
1541157
CUSIP
00972G207
Shares Outstanding
91,567,009,533
13F Activity (30d)
2 filings
1 filers
Portfolio holdings reported by registered funds to the SEC on Form N-PORT — the individual securities a fund owns. Only mutual funds, ETFs and closed-end funds file N-PORT, so operating companies show no data.
No Fund Holdings Data
No Form NPORT-P portfolio reports are available for this stock yet. Only registered investment companies — mutual funds and ETFs — file NPORT-P.